Q1 2024 Autolus Therapeutics PLC Earnings Call Transcript

May 17, 2024 / 12:30PM GMT
Operator

Hello, ladies and gentlemen, and welcome to the Autolus Therapeutics Call to discuss its first quarter 2024 financial results and business update. As a reminder, this conference call is being recorded. I would now like to turn the conference over to your host, Olivia Manser. Please go ahead.

Olivia Manser - Autolus Therapeutics PLC - Director, Investor Relations

Thanks, Tanya. Good morning or good afternoon, everyone. Thanks for joining us on today's call. With me today are Dr. Christian Itin, our CEO; and Rob Dolski, our CFO. So on slide 2, before we begin, just like to remind you as usual that during today's call, we will make statements related to our business that are forward-looking under Federal Securities Laws and the Safe Harbor Provisions Private Securities Litigation Reform Act of 1995.

These may include, but are not limited to statements regarding the status of clinical trials and development and/or regulatory timelines for our product candidate and our expectations regarding our cash runway. These statements are subject to a variety of risks

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot